作者
Pascal Richette, M Doherty, E Pascual, V Barskova, F Becce, J Castañeda-Sanabria, M Coyfish, S Guillo, TL Jansen, H Janssens, F Lioté, C Mallen, G Nuki, F Perez-Ruiz, J Pimentao, Leonardo Punzi, T Pywell, A So, AK Tausche, T Uhlig, J Zavada, W Zhang, F Tubach, T Bardin
发表日期
2017/1/1
来源
Annals of the rheumatic diseases
卷号
76
期号
1
页码范围
29-42
出版商
BMJ Publishing Group Ltd
简介
Background
New drugs and new evidence concerning the use of established treatments have become available since the publication of the first European League Against Rheumatism (EULAR) recommendations for the management of gout, in 2006. This situation has prompted a systematic review and update of the 2006 recommendations.
Methods
The EULAR task force consisted of 15 rheumatologists, 1 radiologist, 2 general practitioners, 1 research fellow, 2 patients and 3 experts in epidemiology/methodology from 12 European countries. A systematic review of the literature concerning all aspects of gout treatments was performed. Subsequently, recommendations were formulated by use of a Delphi consensus approach.
Results
Three overarching principles and 11 key recommendations were generated. For the treatment of flare, colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), oral or intra-articular …
学术搜索中的文章
P Richette, M Doherty, E Pascual, V Barskova, F Becce… - Annals of the rheumatic diseases, 2017